66
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight

, , , , &
Pages 861-870 | Published online: 08 May 2018

References

  • WangYWangYZhaoXClopidogrel with aspirin in acute minor stroke or transient ischemic attackN Engl J Med2013369111923803136
  • WongKSWangYLengXEarly dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysisCirculation2013128151656166624030500
  • WongKSChenCFuJCLAIR study investigatorsClopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trialLancet Neurol20109548949720335070
  • KernanWNOvbiageleBBlackHRGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20144572160223624788967
  • BathPMAppletonJPBeridzeMBaseline characteristics of the 3096 patients recruited into the ‘Triple Antiplatelets for Reducing Dependency after Ischemic Stroke’ trialInt J Stroke201712552453827811309
  • BhattDLFoxKAHackeWCHARISMA InvestigatorsClopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsN Engl J Med2006354161706171716531616
  • KennedyJHillMDRyckborstKJEliasziwMDemchukAMBuchanAMFASTER InvestigatorsFast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trialLancet Neurol200761196196917931979
  • NgMFlemingTRobinsonMGlobal, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet2014384994576678124880830
  • SerenaJSeguraTRoquerJGarcia-GilMCastilloJStudyAThe ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic strokeBMC Neurol2015152825884666
  • WangYJohnstonSCCHANCE InvestigatorsRationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular eventAm Heart J20101603380386.e38120826243
  • HarrisRZBenetLZSchwartzJBGender effects in pharmacokinetics and pharmacodynamicsDrugs19955022222398521756
  • The Nutrition and Chronic Desease Status of Chinese People (2015) [online] Available from: http://www.nhfpc.gov.cnAccessed November 01, 2016
  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigatorsN Engl J Med19933296736828204123
  • JohnstonSCEastonJDFarrantMPlatelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designInt J Stroke20138647948323879752
  • PankertMQuiliciJLoundouADImpact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stentingAm J Cardiol20141131545924182762
  • HaberkaMMizia-StecKLasotaBKyrcz-KrzemienSGasiorZObesity and antiplatelet effects of acetylsalicylic acid and clopidogrel in patients with stable angina pectoris after percutaneous coronary interventionPol Arch Med Wewn2015125962063026252050
  • Garcia-LabbeDRukaEBertrandOFVoisinePCosterousseOPoirierPObesity and coronary artery disease: evaluation and treatmentCan J Cardiol201531218419425661553
  • BadimonLHernandez VeraRPadroTVilahurGAntithrombotic therapy in obesityThromb Haemost2013110468168823571816
  • SerebruanyVLFortmannSDKimMHShould the dose of antiplatelet drugs be adjusted for body weight? The example of vorapaxarCardiology20161332697226488178
  • TARDIS Trial InvestigatorsKrishnanKBeridzeMSafety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)Int J Stroke20151071159116526079743
  • SibbingDvon BeckerathOSchomigAKastratiAvon BeckerathNImpact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary interventionAm J Cardiol2007100220320517631070
  • CuissetTFrereCQuiliciJRelationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non responseThromb Res2009123459760318499233